Compounding pharmacies producing and distributing educational videos to healthcare providers on the benefits and uses of specific compounded drugs face a regulatory minefield of compliance considerations. Understanding these considerations can help pharmacies remain compliant with federal and state regulations while providing valuable educational content.
Blog
Tirzepatide Compounding Update
The FDA has stated that it does not intend to take action against compounders for violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) arising from conditions that depend on tirzepatide's inclusion on the FDA drug shortage list. Compounding pharmacies should still exercise their own ...